Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

BTOG 2025 | Challenges in treating HER2-mutant lung cancer and emerging therapeutic approaches

Samreen Ahmed • 4 Mar 2025
BTOG 2025
Breast Cancer Lung Cancer Antibodies

More from Samreen Ahmed

Osimertinib and chemotherapy as the standard of care in EGFRm NSCLC
1:40
Osimertinib and chemotherapy as the standard of care in EGFRm NSCLC
Samreen Ahmed • 8 Sep 2025
FLAURA2 outcomes by EGFR mutation subtype in advanced NSCLC
1:34
FLAURA2 outcomes by EGFR mutation subtype in advanced NSCLC
Samreen Ahmed • 8 Sep 2025
Optimizing immunotherapy in lung cancer: balancing intensification and de-escalation
1:18
Optimizing immunotherapy in lung cancer: balancing intensification and de-escalation
Samreen Ahmed • 4 Mar 2025
Evolving treatment strategies for early-stage lung cancer with immunotherapy
1:46
Evolving treatment strategies for early-stage lung cancer with immunotherapy
Samreen Ahmed • 4 Mar 2025

Related Videos

Stress and depression linked to tumor transcriptional signatures in breast cancer
1:21
Stress and depression linked to tumor transcriptional signatures in breast cancer
Shipra Gandhi • 31 May 2026
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
1:13
DESTINY-Breast07: final analysis of T-DXd and durvalumab in 1L HER2+ breast cancer
Shipra Gandhi • 31 May 2026
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
1:34
TBCRC-053: preoperative radiotherapy & pembrolizumab in node-positive TNBC
Shipra Gandhi • 1 Jun 2026
AI decision support in EGFR-mutant metastatic non-small cell lung cancer
3:12
AI decision support in EGFR-mutant metastatic non-small cell lung cancer
Chinmay Jani • 31 May 2026
The content of VJOncology is intended for healthcare professionals